Development↦Ethics and Laws↦Ethics Application↦Submission
What is it? Why is it important?
Prior to study implementation, interventional and observational studies must be submitted to the Ethics Committee (EC) for approval (e.g. interventional studies with IMP/IMD, transplantation studies, stem cell studies, research with deceased persons, and research projects with the further-use of Biological Material (BM) or Health related Personal Data (HrPD)).
An EC review is based on a predefined list of documents submitted by the SP-INV (e.g. the application dossier). The HRA ordinances provide respective itemised lists of required submission documents (e.g. ClinO, ClinO-MD, HRO)
In Swiss multi-centre studies:
- The Lead-EC:
- Reviews the study application dossier (e.g. research and scientific aim, study protocol, feasibility, safety, research integrity, contractual agreements, monitoring)
- Approves the SP-INV site (responsible for the initiation and coordination of the study)
- The Local-EC checks and approves local conditions (e.g. PIS / ICF / Contracts)
More
In the event a Local-EC does not approve study conduct at a particular site, the Lead-EC:
- Can only authorise site(s) for study start that have a joint Lead and local-EC(s) approval
- Will request modifications or additional information in order to allow site study start
What do I need to do?
As a SP-INV, access the swissethics website:
- Locate the EC responsible for your canton
- For document submission, go to the BASEC portal and:
- Register by creating a login account
- Click on “Submit an application”
- Enter your study type: IMP, MD, HRO, or other
- Fill in the form and upload relevant study documents
In the event of a problem or unresolved questions, each EC has a scientific secretarial office that can be contacted for assistance.
EC support might include:
- The risk-categorisation of your study
- Submission and processing timelines
- Administrative concerns
- Expected EC administrative fees
Where can I get help?
Your local CTU↧ can support you with experienced staff regarding this topic
Basel, Departement Klinische Forschung, CTU, dkf.unibas.ch
Lugano, Clinical Trials Unit, CTU-EOC, www.ctueoc.ch
Bern, Clinical Trials Unit, CTU, www.ctu.unibe.ch
Geneva, Clinical Research Center, CRC, crc.hug.ch
Lausanne, Clinical Research Center, CRC, www.chuv.ch
St. Gallen, Clinical Trials Unit, CTU, www.kssg.ch
Zürich, Clinical Trials Center, CTC, www.usz.ch
External Links
Swissethics – see in particular
- BASEC: the EC submission portal
- Ethic committees: a list of all Swiss ECs
- Templates / Checklists: for PIS, ICF, study protocol
Regional / Cantonal EC – see in particular topics
- Legal framework
- Type of project not requiring EC approval
- Dossier preparation
- Submission procedures
References
ICH GCP E6(R2) – see in particular guideline
- Chapter 3 EC responsibilities, composition, procedures
ISO 14155:2020 Medical device (access liable to cost) – see in particular chapter
- Chapter 5 Ethical considerations
Swiss Law
HRA – see in particular articles
- Art. 45-55 EC Role, responsibilities, composition, operations, procedures, records
ClinO – see in particular articles
- Art. 23 Coordination in authorisation procedures
- Art. 24 Application
- Art. 27 Multi-centre trials
ClinO-MD – see in particular articles
- Art. 9 Coordination in authorisation procedures
- Art. 10 Application
- Art. 13 Multi-centre trials
HRO – see in particular articles
- Art.14 Application
- Art. 17 Multi-centre projects